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Retinal ischemia/reperfusion (I/R) injury is an important cause of visual impairment. However, questions remain on
the overall I/R mechanisms responsible for progressive damage to the retina. In this study, we used a mouse model
of I/R and characterized the pathogenesis by analyzing temporal changes of retinal morphology and function
associated with changes in retinal gene expression. Transient ischemia was induced in one eye of C57BL/6 mice by
raising intraocular pressure to 120 mmHg for 60 min followed by retinal reperfusion by restoring normal pressure.
At various time points post I/R, retinal changes were monitored by histological assessment with H&E staining and
by SD-OCT scanning. Retinal function was also measured by scotopic ERG. Temporal changes in retinal gene
expression were analyzed using cDNA microarrays and real-time RT-PCR. In addition, retinal ganglion cells and
gliosis were observed by immunohistochemistry. H&E staining and SD-OCT scanning showed an initial increase
followed by a significant reduction of retinal thickness in I/R eyes accompanied with cell loss compared to
contralateral control eyes. The greatest reduction in thickness was in the inner plexiform layer (IPL) and inner
nuclear layer (INL). Retinal detachment was observed at days 3 and 7 post- I/R injury. Scotopic ERG a- and b-wave
amplitudes and implicit times were significantly impaired in I/R eyes compared to contralateral control eyes.
Microarray data showed temporal changes in gene expression involving various gene clusters such as molecular
chaperones and inflammation. Furthermore, immunohistochemical staining confirmed Müller cell gliosis in the
damaged retinas. The time-dependent changes in retinal morphology were significantly associated with functional
impairment and altered retinal gene expression. We demonstrated that I/R-mediated morphological changes the
retina closely associated with functional impairment as well as temporal changes in retinal gene expression. Our
findings will provide further understanding of molecular pathogenesis associated with ischemic injury to the retina.Introduction
Retinal ischemia, often referred as “stroke of retina”, is
an important cause of visual impairment in retinal vas-
cular occlusion, diabetic retinopathy, glaucoma, and ocu-
lar trauma [1-5]. It is caused by a reduction of the
retinal blood supply that decreases the delivery of oxy-
gen and other nutrients to various retinal layers.* Correspondence: Abe.Clark@unthsc.edu
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reproduction in any medium, provided the orReperfusion of blood following ischemia is associated
with oxidative stress and inflammatory responses [6]. In
particular, resulting retinal ganglion cell (RGC) death is
caused by a variety of cell death mechanisms including
necrosis, apoptosis, necroptosis and autophagy after is-
chemia/reperfusion (I/R) injury [7-9]. To better under-
stand the pathophysiological mechanisms associated
with retinal I/R injury, several different experimental ap-
proaches have been designed in rodent models [8,10-12].
The “pressure-induced retinal I/R model” involves
cannulation of the ocular anterior chamber followed by
raising intraocular pressure above systolic blood pres-
sure. After a specified period of time, the cannula is. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kim et al. Molecular Neurodegeneration 2013, 8:21 Page 2 of 19
http://www.molecularneurodegeneration.com/content/8/1/21removed allowing restoration of retinal blood flow. This
model has been used for the investigation of ischemia-
derived ocular pathologies such as glaucoma and dia-
betic retinopathy [13,14]. This model currently is the
most widely used method to study ocular diseases re-
lated to retinal ischemia.
Retinal damage due to I/R injury is associated with the
loss of neurons, morphological degeneration of the ret-
ina, loss of retinal function, and ultimately vision loss
[15-17]. Although degeneration times vary in different
experimental conditions, I/R-induced injury and retinal
degeneration is initially observed primarily in inner ret-
inal layers [e.g. the inner plexiform layer (IPL) and inner
nuclear layer (INL)] that are supplied by the central ret-
inal artery, in contrast to the outer nuclear layer (ONL)
that is generally less affected [18-21]. Differently from
inner retinal layers, the choroid supplies blood and nu-
trients to the photoreceptors and ONL [22,23]. This
structural difference may influence the initiation stage of
I/R injury. Furthermore, morphological changes are
often associated with functional impairment of the retina
[24-26]. However, the correlation between morpho-
logical and functional changes with molecular mecha-
nisms from different stages of pathogenesis associated
with retinal I/R injury in retina is poorly characterized.
Several signaling pathways have been reported as key
molecular events related to the degeneration or protec-
tion of RGCs and their axons in retinal I/R injury. In-
creased nuclear factor (NF)-κB p65 immunoreactivity was
associated with retinal degeneration following retinal is-
chemia and reperfusion injury in mice [27], and inactiva-
tion of astroglial NF-κB promotes survival of retinal
neurons following ischemic injury [28]. In addition to NF-
κB, cyclooxygenease-2 appears to play a critical role in
RGC death after transient ischemia [29]. Activation of
Stat3 protects retinal ganglion cell layer neurons in re-
sponse to transient retina ischemia in mice [30]. Several
reports have indicated that inflammatory responses associ-
ated with the innate and adaptive immune system are
major pathological processes in retinal I/R injury. These
include toll-like receptor 4, complement component C3,
tumor necrosis factor receptor, and surface molecule
CD40 that are associated with functional impairment, ret-
inal layer morphological changes, and/or loss of RGCs
[20,31-33]. However, further studies are still required to
define and better understand pathologic progression in-
cluding temporal changes in retinal morphology, function,
and molecular signaling.
In our study, we used a mouse model of pressure-
induced retinal I/R injury and characterized morpho-
logical changes in retinal layers associated with retinal
ERG functions. Using histological analysis and SD-OCT
(spectral domain-optical coherence tomography) scan-
ning, we showed progressive morphological changes ofretinal layers at various times after I/R injury. In
addition, we used scotopic electroretinography (ERG) to
demonstrate functional deficits after I/R injury that
corresponded to the morphological changes. We also
profiled changes in retinal gene expression associated
with I/R injury at various time points using cDNA
microarray analysis to correlate the molecular mecha-
nisms with morphological and functional changes.
Material and methods
Mice
Female C57BL6/J mice (8-10 weeks of age) were main-
tained in 12:12 light /dark cycle under optimal temperature
and humidity controlled conditions. All studies were ap-
proved by University of North Texas Health Science
Center’s Institutional Animal Care and Use Committee
(IACUC) and complied with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
Pressure induced retinal ischemia
Mice were anesthetized using a ketamine/xylazine
cocktail (100/10 mg/kg). While anesthetized, mice
were placed on a heating pad to prevent hypothermia.
Mydfrin (Alcon, Inc. Fort Worth, TX) was topically ad-
ministered to the test eye to dilate the iris. A 30-gauge
needle connected to saline reservoir was inserted into
the anterior chamber through the cornea of left eyes. In-
traocular pressure was raised to 120 mmHg for 60 min.
Retinal ischemia was confirmed by blanching of the ret-
ina using an ophthalmoscope. Contralateral right eyes
served as controls. The needle was removed after 60 mi-
nutes to allow reperfusion of the retina. Tobrex (Alcon
Inc. Fort Worth, TX) was topically administered to pre-
vent ocular infection.
Spectral domain-optical coherence tomography (SD-OCT)
Mouse retinas were scanned with an SD-OCT Ophthal-
mic Imaging System (Bioptigen Inc. Durham, NC).
Briefly, mice were anesthetized using a ketamine/
xylazine cocktail (100/10 mg/kg) and placed on the
mouse holder to fix the mouse posture for scanning.
The retina was scanned with rectangular scanning mode
(1.2 mm diameter) consisting of 100 B scans/1000 A
scans per B scan using InVivoVue software (Bioptigen
Inc, Durham, NC). Superior, center and inferior images
were imported and analyzed by ImageJ software (NIH)
with four vertical calipers on each retinal layer (n = 4-5
mice per time point).
Flash scotopic electroretinogram (ERG)
Mice were dark adapted for 16 hrs. After anesthesia with
Ketamine/Xylazine (100/10 mg/kg), mice were placed
in a Gantzfield light chamber on the LKC electroretino-
gram system (LKC Technologies Inc., Gaithersburg,
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implicit times of ERG waveforms were measured at a
series of flash intensities (-30, -20, -10, 0, 5, 10, 15 dB)
(n = 9 mice per time point).
Histology and cell counting in RGC layer
Eyes were harvested and fixed in neutral buffered 10%
or 4% paraformaldehyde. After paraffin embedding, ret-
inal cross sections were prepared (5 μm) followed by
Hematoxylin-Eosin (H&E) staining for morphological
observation of the retinal layers. Four retinal sections
from ora serrata to ora serrata through the optic nerve
head were chosen from each eye and the cells in the
RGC layer were counted and averaged. Day 0 RGC
counts from non-ischemic control eyes were set as
100%, and RGC cell counts in the rest of the eyes were
compared to these controls.
Analysis of retinal thickness
H&E stained whole retina or individual retinal layer
thicknesses were measured using ImageJ software (NIH).
Individual or whole (RGCL to ONL) layer thickness
from 4 retinal cross-sections per eye were measured at
quarterly points for each retinal cross-section and aver-
aged. For SD-OCT images, layer thickness at 2 different
distances from optic nerve head (~0.35 and 0.55 μm)
was determined and averaged. Averaged retinal thickness
was converted to the percentage of the thicknesses from
day 0 non-ischemic contralateral eyes.
RNA extraction and DNA microarray analysis
Total retinal RNA was extracted from control and I/R
injured eyes. Retinas were collected and homogenized in
Iso-RNA Lysis Reagent (5 PRIME Inc. Gaithersburg,
MD). Total RNA was further extracted using an RNeasy
Micro Kit (QIAGEN Science, Germantown, MD). RNA
quality was controlled by determining RNA integrity
number (RIN) using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA) with nano- or
picochip systems. Total RNA with RINs >7 were selected
and pooled from either control or experimental eyes at
each time point for gene expression microarray analysis.
Microarray hybridizations were performed at the Univer-
sity of Iowa DNA Core Facility. Briefly, 50 ng total RNA
was converted to SPIA amplified cDNA using the WT-
Ovation Pico RNA Amplification System, v2 (NuGEN
Technologies, San Carlos, CA, Cat. #3302) according to
the manufacturer’s recommended protocol. The ampli-
fied SPIA cDNA product was purified through a
QIAGEN QIAquick PCR Purification column (QIAGEN
Cat #28104) according to modifications from NuGEN.
Five microgram samples were fragmented (average frag-
ment size = 85 bases) and biotin labeled using the
NuGEN FL-Ovation cDNA Biotin Module (NuGENTechnologies, Cat. #4200) per the manufacturer’s
recommended protocol. The resulting biotin-labeled
cDNA was mixed with Affymetrix eukaryotic hybridiza-
tion buffer (Affymetrix, Inc., Santa Clara, CA), placed
onto Affymetrix Mouse Gene 1.0 ST arrays (Part No.
901168) (Affymetrix Inc. Santa Clara, CA), and incu-
bated at 45°C for 18 h with 60 rpm rotation in an
Affymetrix Model 640 Genechip Hybridization Oven.
Following hybridization, the arrays were washed, stained
with streptavidin-phycoerythrin (Molecular Probes, Inc.,
Eugene, OR), and the signals were amplified with
anti-streptavidin antibody (Vector Laboratories, Inc.,
Burlingame, CA) using the Affymetrix Model 450 Fluid-
ics Station. Arrays were scanned with the Affymetrix
Model 3000 scanner with the 7G upgrade and data were
collected using the using the GeneChip operating soft-
ware (GCOS) v1.4.
Bioinformatic analysis
The 16 data CEL files for all 8 time points (0, 6 hr., 1, 3,
7, 14, 21 and 28 days) after I/R injury were imported
into the Partek Genomics Suite 6.6 software (Partek Inc.,
Louis, MO) and normalized based on robust multi-array
averaging (RMA). At each time point, the retinal I/R
sample was compared to the contralateral control sam-
ples to calculate the microarray ratios and log2 fold
change values. Using Excel, the selective filter of ≥1.5
fold change was utilized to identify up-regulated genes
and ≤ -1.5 for the down-regulated genes per time point
for the retina datasets. The genes were further analyzed
using the publicly available bioinformatics software DA-
VID (Database for Annotation, Visualization and Inte-
grated Discovery). Gene ontology (GO) based cluster
analysis was performed to identify possible enrichment
of genes (GO enrichment score calculated using a χ2
test) using filtered genes from each time point. The Fish-
ers Exact p value is calculated by DAVID to identify GO
enrichment based clusters, and p values <0.05 were con-
sidered to be significant in the enriched annotation cat-
egory based on the Benjamini multiple test correction
[34,35]. Clusters of genes were identified at specific time
points and changes in gene expression were graphed
temporally for each GO category.
Real-time reverse transcription (RT)-polymerase chain
reaction (PCR)
Complementary DNA (cDNA) was generated from the
individual retinal RNA samples (n = 4-5) that were
pooled for the microarray study. 2 μg of total RNA was
used for reverse transcription (RT) at 25°C (10 min),
37°C (120 min) and 85°C (5 min) using a Multiscribe
reverse transcriptase kit (Applied Biosystems, Life Tech-
nologies Corp., Grand Island, NY) and a PTC-100
thermal cycler (MJ Research Inc. Waltham, MA). Gene
Kim et al. Molecular Neurodegeneration 2013, 8:21 Page 4 of 19
http://www.molecularneurodegeneration.com/content/8/1/21expression of cryaa, cryba1, ccl12, c3 and gapdh was an-
alyzed using Taqman gene expression assay primer sets
(Applied Biosystems, Life Technologies Corp., Grand
Island, NY) with Taqman Fast Advanced Master Mix
(Applied Biosystems, Life Technologies Corp., Grand
Island, NY) on a CFX96 real-time system (Bio-Rad, Life
Science Research, Hercules, CA) with recommended
thermal cycles by manufacturer (hold 50°C (2 min), hold
95°C (20 sec), 40 cycles of denaturation (3 sec) and
annealing /extension (30 sec)). The expression of the
housekeeping gene gapdh was used as an internal
control to normalize target gene expression between
samples. Differences in target gene expression were
calculated using the following formula: ΔΔCT =ΔCT
(target gene) – ΔCT (gapdh). The ΔΔCT value of cDNA
amplification from the I/R eye was normalized to the
control right eye. 0 hr was set as 1 and data from other
time points were expressed as fold difference compared
to 0 hr data.
Immunohistochemistry
Sections of paraffin embedded retinas were subjected to
antigen retrieval in citrate buffer (pH 6.0), and the slides
were washed twice in PBS. Slides were blocked for 1 hr
using SuperBlock Blocking Buffer (Thermo Scientific,
Rockford, IL), and then incubated with mouse anti-
Brn3a (1:50) (Cat # MAB 1585, EMD Millipore Corp.
Billerica, MA), mouse anti-NeuN (1:1000) (Cat # MAB
377, EMD Millipore Corp. Billerica, MA), or rabbit anti-
GFAP (1:200) (glial fibrillary acidic protein) (Abcam plc.Figure 1 I/R induced retinal detachment at day 3 and day 7 after inju
photoreceptor/RPE layer on days 3 and 7 after I/R injury. We confirmed I/R
points (lower panels). The contralateral eyes served as controls and had no
selected from the same mouse used for SD-OCT scanning (n = 4-5) or H&Ecat.# ab7779, Cambridge, MA) for 16 hr. at 4°C,
followed by washing and then incubation with goat anti-
mouse antibody (1:500) or goat anti-rabbit antibody
(1:500) conjugated with Alexaflour 488 (Cat.# A11001 or
A11008, Invitrogen, Life Technologies, Grand Island,
NY) for 1 hr. at room temperature. Cover slips were
mounted using ProlongGold anti-fade reagent with
DAPI (Molecular probes, Life Technologies, Grand
Island, NY) for nuclear visualization. Images were ac-
quired using a Nikon Eclipse Ti inverted microscope
(Nikon Instruments Inc. Melville, NY) and a CRi
Nuance FX multispectral imaging system (Caliper Life
Sciences, Hopkinton, MA). Autofluorescence was sub-
tracted using the Nuance 3.0 software.Results
I/R induced retinal detachment after 3 and 7 days
During SD-OCT scanning, we first observed retinal de-
tachment in all ischemic eyes 3 days after I/R injury.
The detachment was also observed in I/R injured eyes at
7 days (Figure 1) and recovered by 14 days (data not
shown). We morphologically confirmed similar retinal
detachment 3 and 7 days after I/R injury by histological
assessment of H&E stained retinas. In contrast, no mor-
phological changes were observed in both SD-OCT and
histological assessment from contralateral control eyes
at day 3 from (Figure 1). The morphology of day
7-control eyes was not significantly different from day 3
eyes (data not shown).ry. SD-OCT scanning (upper panel) showed retinal detachment at the
-induced retinal detachment using retinal H&E staining at the same
detachment. Representative images of control or I/R retinas were
staining (n = 9-10).
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retinal layers (IRLs) and decreased cell numbers in the
retinal ganglion cell layer
Histological measurements of H&E stained retinas
showed that I/R injury significantly (p < 0.05) increasedFigure 2 I/R induced time-dependent degeneration of inner retinal la
assessment by H&E staining 3, 7, 14, 21 and 28 days after I/R injury with ap
(from NFL/RGCL to ONL) or sub-layer (IPL, INL and ONL) thickness at each
mean ± standard error of percentages at each time point from both contro
100%. For statistical analysis, two-way ANOVA (analysis of variance) was app
differences (p < 0.05) between control and I/R eyes at each time point. (NF
layer, INL: inner nuclear layer, ONL: outer nuclear layer).retinal thickness of the inner retinal layers (IRLs), IPL
and INL, at day 3 followed by progressive decreases in
thickness after 14 days (Figure 2A and 2B). In addition,
IRL thickness was significantly (p < 0.05) decreased at
21 and 28 days after injury compared to contralateralyers. Control and I/R mouse eyes were collected for histological
proximately 9-10 mice per time point. Whole retinal thickness
time point was measured and statistically analyzed. Data represent
l and I/R eyes compared to the day 3-control eyes, which were set as
lied with the Bonfferoni post-hoc test. Asterisks indicate statistical
L/RGCL: nerve fiber layer/retinal ganglion cell layer, IPL: inner plexiform
Figure 3 Similar morphological changes were observed in I/R-injured retinal layers using non-invasive SD-OCT scanning. Morphological
changes in retinal layers were monitored using SD-OCT scanning. Time-dependent changes in retinal thickness were analyzed from whole retina
(from RGCL to ONL) or retinal sub-layers (IPL, INL and ONL) at each time point. Data represent mean ± standard error of percentages at each time
point from both control and I/R eyes compared to day 3-control eyes, set as a 100%. For statistical analysis, two-way ANOVA (analysis of variance)
was applied followed by the Bonfferoni post-hoc test. Asterisks indicate statistical differences (p < 0.05) between control and I/R eyes at each time
point. (RGCL: retinal ganglion cell layer, IPL: inner plexiform layer, INL: inner nuclear layer, ONL: outer nuclear layer).
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creased in only IRLs, IPL and INL, but not in the ONL
(Figure 2B). We also observed similar trend changes
using SD-OCT scanning. I/R injury significantly in-
creased retinal thickness at early time points (3 and 7
days) followed by progressive decreases in retinal layer
thickness over the remaining 28 days (Figure 3A and
3B). SD-OCT scanning also showed that the inner ret-
inal layers (IPL and INL) were the sites of greatest dam-
age induced by I/R injury (Figure 3A and 3B).
In addition, we counted cells in the RGC layer at 3,
7, 14, 21 and 28 days after I/R injury (Figure 4).
Cell numbers in the RGC layer were significantly
(p < 0.05) decreased compared to contralateral eyes
beginning 14 days after I/R injury and further de-
creased over 28 days by approximately 30%, which
correlates with morphological changes of I/R-injured
retinal layers shown in Figures 2 and 3. We also con-
firmed our finding with RGC-specific Brn3a and
NeuN immunohistochemical labeling. Our immuno-
staining data (Figure 5) also showed a significant 30%
loss in RGCs 28 days post injury (p < 0.05). Since only
approximately half of the cells in the RGCL are
RGCs, these results suggest I/R damage to other
RGCL cells (i.e. displaced amacrine cells).Figure 4 Cell numbers in retinal ganglion cell layer (RGCL)
progressively decreased after retinal I/R injury. Total cell
numbers in RGCL were counted from control or I/R-injured eyes
(n = 9-10 per group) at each time point (3, 7, 14, 21 and 28 days)
after I/R injury. Data represent mean ± standard error of cell number
percentages at each time point from both control and I/R eyes
compared to day 3-control eyes, set as 100%. Two-way ANOVA
(analysis of variance) was applied with Bonfferoni post-hoc test for
statistical analysis. Asterisks indicate statistical differences (p < 0.05)
between control and I/R eyes at each time point.I/R induced retinal functional impairment beginning 3
days after injury
In mouse eyes, 92 ~ 98% of the photoreceptors are rods,
dominantly responsible for functional vision in this spe-
cies [36,37]. Therefore, we used scotopic ERG to exam-
ine retinal function through amplitudes and implicit
times of ERG a- and b-waves at 7, 14, 21, 28 and 35 days
after I/R. No statistical changes were observed in a-wave
amplitudes at 7 and 14 days after I/R injury, but ampli-
tudes were significantly (p < 0.05) decreased at 21 and 28
days at higher light intensities (0, 5, 10 and 15 dB) in I/R
injured eyes compared to contralateral control eyes.
Interestingly, the a-wave amplitudes recovered at 35 day
and did not show a statistical difference with the contra-
lateral eyes. In contrast, b-wave amplitudes were signifi-
cantly (p < 0.05) decreased by I/R injury at day 7 and
continuously decreased (p < 0.05) over 35 days (Figure 6).
We also measured changes in implicit times of a- and
b-waves to monitor time latency. ERG a-wave implicit
times did not significantly change at 7, 14 and 21 days
after I/R injury but significantly increased at lower light
intensities (-30 and -20 dB) by 28 and 35 days. In con-
trast, I/R injury significantly (p < 0.05) increased b-wave
implicit times through all time points (7, 14, 21, 28 and
35 days) compared to contralateral eyes (Figure 7).
I/R injury differentially altered expression of retinal genes
at different time points
We isolated total RNA from I/R-injured or contralateral
retinas and analyzed gene expression profiles by micro-
array analysis at various time points (0, 6 hr., 1, 3, 7, 14,
21, 28 days) after I/R injury. Microarray data from I/R in-
jured eyes were normalized based on the robust multi-
array averaging (RMA) with contralateral control eyes
using the Partek Genomics Suite 6.6 software. After selec-
tion of 1.5 or -1.5 fold (log2) up-or down-regulated genes,
data were further analyzed using DAVID for gene cluster-
ing based on ontological identification using three cat-
egories: biological process (BP), molecular function (MF)
and cellular function (CC). Up-regulated gene clusters are
shown in Table 1. Gene clusters related with eye develop-
ment were up-regulated at the earlier time points (6 hr., 1,
3, 7 days). This cluster included crystallin genes such as
cryaa and cryba1. Up-regulation of these two genes was
maximal (~20 fold log2 scale) at day 1 (Figure 8B), but ex-
pression was down-regulated at day 14 (Table 2). In con-
trast, gene expression of mbp (myelin basic protein) and
atf3 were consistently maintained through all time points.
At all time points after I/R injury, gene clusters associated
with inflammation such as inflammatory response,
defense response or immune response were also up-
regulated (Table 1). Complement genes c3 and c4b, the
chemokine gene ccl12, and gfap (glial fibrillary acidic pro-
tein) were identified in the gene clusters for inflammation
Figure 5 Retinal I/R injury induced a significant decrease of Brn3a + or NeuN + positive RGCs 28 days post injury. Retinas from 28 days
post-I/R were stained for RGC markers Brn3a or NeuN. Total RGC numbers were counted from control or I/R-injured eyes (n = 4 per group). Data
represent mean ± standard error of cell number percentages from both control and I/R eyes compared to non-injured control eyes, set as 100%.
The student’s paired t-test was performed for statistical analysis. Asterisks indicate statistical differences (p < 0.05) between control and I/R eyes.
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at day 1, whereas the other genes (e.g. gfap) were gradually
up-regulated and maintained throughout the time course.
In addition, expression of apoptosis/cell death-related
genes also increased, including stat3, gpx3 (glutathione
peroxidase 3), bcl6, and casp8 (caspase 8) (Figure 8A).
Among various genes with altered expression, we
selected cryaa, cryba1, ccl12 and c3 to validate our
microarray data using real-time RT-PCT (Figure 9). In
agreement with our microarray data, gene expression of
cryaa and cryba1 was significantly (p < 0.05) increased
by ~84 and ~60 fold 24 hr after I/R injury. ccl12 expres-
sion was also significantly (p < 0.05) increased ~50 fold
at 6 and 24 hrs. after I/R injury. c3 expression showed
similar trend with microarray data for increased expres-
sion, but was not statistically different from controls due
to variation of individual expression levels (Figure 9).
I/R injury time-dependently increased retinal GFAP
In order to confirm increased retinal gfap mRNA
expression, we evaluated GFAP immunostaining in
the retinas of I/R injured and control eyes. Increased
expression of GFAP is often used as a pathologicalgliosis marker associated with neuronal injury. In the
retina, Müller cells and astrocytes are the major cell
types that express GFAP, and its expression is in-
creased in several ocular pathologies. In particular,
gliosis in the Müller cells occurs through whole ret-
inal layers under several inflammatory conditions
[38-40]. As predicted by our gene array data, GFAP
expression was up-regulated 3 days after I/R injury.
GFAP expression was observed through the ONL at
day 7, with maximal expression 14 days after I/R in-
jury. After 21 days, the GFAP intensity decreased and
was restricted to IRLs at 28 days after I/R injury
(Figure 10). In contrast, there was no remarkable
change in retinal GFAP expression of contralateral
eyes at any time point (Figure 10). GFAP expression
in control eyes was restricted to the RGCL, most
likely due to astrocytes and/or Müller cell end feet.
The increased GFAP staining in the I/R injured ret-
inas shared morphological features of Müller cells.
Discussion
Ischemic damage to different tissues such as brain and
kidney share many similar pathologies [41,42]. In
Figure 6 I/R injury impaired retinal function. Using electroretinography (ERG), the a- and b- wave amplitudes were measured from injured
contralateral control eyes and I/R-injured eyes (n = 9 mice per group) under a series of light intensities (-30, -20, -10, 0, 5, 10, 15 dB) at 5 time
points (7, 14, 21, 28 and 35 days) after I/R injury. Data represent mean ± standard error of a- or b-wave amplitudes (micro voltage) at each light
intensity from both control and I/R eyes. Two-way ANOVA (analysis of variance) was applied with the Bonfferoni post-hoc test for statistical
analysis. Asterisks indicate statistical differences (p < 0.05) between control and I/R eyes at each light intensity.
Kim et al. Molecular Neurodegeneration 2013, 8:21 Page 9 of 19
http://www.molecularneurodegeneration.com/content/8/1/21particular, retinal I/R results in neuronal degeneration
associated with visual impairment and irreversible de-
struction of many layers of the structurally complexretina. Common morphological features in rodent
models of retinal I/R include morphological degener-
ation of retinal layers, RGC death, and impairment of
Figure 7 I/R injury induced time latency in ERG waves. The implicit times (i.e. latency times) of a- and b-waves were measured at varying
light intensities during ERG recording (n = 9) at 7, 14, 21, 28 and 35 days after I/R injury. Data represent mean ± standard error of a- or b- wave
implicit times at each light intensity from both control and I/R eyes. Two-way ANOVA (analysis of variance) was applied with the Bonfferoni
post-hoc test for statistical analysis. Asterisks indicate statistical differences (p < 0.05) between control and I/R eyes at each light intensity.
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all pathological mechanisms, we observed pathological
progression of I/R injury over 35 days, studying impair-
ments in retinal morphology, function, and temporalchanges in gene expression. There was a significant in-
crease in thickness of inner retinal layers 3 days after I/R
injury, most likely due to initial retinal edema. This
histological finding was confirmed using non-invasive
Table 1 Gene ontology clusters in the mouse retina upregulated at various time points after I/R injury
Time Ontology Enrichment score P value (P < 0.05)
0 day No significant changes
6 hr BP eye development 4.82 3.20E-04
inflammatory response 4.49 2.20E-05
apoptosis 1.76 8.40E-03
blood Bessel morphogenesis 0.67 4.00E-02
MF structural constituent of eye lens 4.82 7.80E-09
cytokine activity 3.15 3.80E-04
CC extracellular space 3.15 1.80E-04
1 day BP eye development 8.99 2.10E-09
inflammatory response 3.51 2.20E-03
cell death 1.37 1.10E-02
MF structural constituent of eye lens 8.99 1.80E-15
transcriptional factor activity 1.52 1.80E-02
CC extracellular region part 2.71 1.30E-05
3 day BP inflammatory response 8.12 3.30E-08
eye development 5.29 1.30E-04
cell death 2.21 9.60E-04
MF structural molecule activity 5.29 3.30E-04
CC extracellular region 3.1 5.30E-04
7 day BP defense response 2.83 7.00E-09
eye development 1.59 2.10E-02
MF peptide antigen binding 2.83 1.20E-02
CC extracellular region part 3.62 1.90E-04
antigen processing and presentation 2.83 1.60E-03
14 day BP chemotaxis 3.2 3.90E-03
cell-cell signaling 2.51 1.90E-03
inflammatory response 1.96 6.50E-02
cell death 1.73 3.40E-03
tissue regeneration 1.51 5.60E-03
myelination 1.51 4.90E-02
neuron differentiation 1.35 3.80E-02
MF glutamate receptor activity 3.13 4.80E-04
CC extracellular region 6.58 6.60E-04
neuron projection 4.31 3.30E-06
synapse 3.13 1.20E-05
postsynaptic membrane 3.13 2.80E-03
gap junction 1.64 3.60E-02
21 day BP defense response 1.73 1.10E-02
inflammatory response 1.73 3.00E-02
hemopoiesis 1.3 4.00E-02
MF no significant changes
CC extracellular region part 4.57 1.60E-07
extracellular region 4.57 1.50E-06
proteinaceous extracellular matrix 1.56 2.10E-04
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Table 1 Gene ontology clusters in the mouse retina upregulated at various time points after I/R injury (Continued)
28 day BP immune response 2.46 2.20E-04
protein maturation 2.46 4.50E-02
complement activation 2.46 7.10E-03
MF glycosaminoglycan binding 1.02 5.70E-02
CC extracellular region 3.48 3.90E-04
proteinaceous extracellular matrix 1.36 3.70E-03
After normalization to control eyes, microarray data were filtered to select genes upregulated higher than 1.5 fold (log2). Data were further analyzed using DAVID
(Database for Annotation, Visualization and Integrated Discovery) for gene clustering based on gene ontology to identify potential enrichment of genes. Gene
clusters were identified into 3 categories, biological process (BP), molecular function (MF) and cellular component (CC) at 8 time points (0 hr, 6 hr, 1, 3, 7, 14, 21
and 28 days) after I/R injury.
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clinically and experimentally to detect morphological
features of retina [43-47]. This technique allows live
monitoring of the retina without mechanical invasion or
damage. In contrast, traditional histological assessment
is terminal and can introduce artifacts due to tissue pro-
cessing. SD-OCT scanning allowed us to detect retinal
detachment 3 days post injury in all mice, which was
confirmed by histology (Figure 1). Both techniques con-
firmed time-dependent changes in retinal morphology
after I/R injury.
Previous studies have suggested diverse molecular
events promoting or attenuating I/R-induced retinal dam-
age. A number of neuroprotective approaches have been
tested in retinal I/R models. One major effort was to
define protective mechanisms using pharmacological ap-
proaches. Ueda et al. reported that retinal neuronal injury
occurred by both necrosis and apoptosis, which were
inhibited by treatment with the cognition-enhancer,
Nefiracetam [48]. Sun et al. also demonstrated that Cobalt
protophorphyrin-induced Heme Oxygenase-1 attenuated
I/R induced injury in retina [49]. The hypolopodemic drug
Simvastatin also improved retinal ganglion cell survival in
mouse model of retinal I/R injury [50]. More recently,
Fujita et al. showed that pharmacological blocking of
Angiotensin II type 1 receptor signaling produced neuro-
protection via suppression of ROS production [51]. Gen-
etic disruption of specific genes in mice has also been used
to identify pathogenic and neuroprotective pathways.
Aquaporin-4 null mice were protected from ischemia-
induced retinal functional impairment and cell death [52].
Deletion of complement component C3 also induced ret-
inal protection against I/R injury [32].
It is also important to examine molecular mechanisms
associated with progression of retinal injury. cDNA
microarray analysis is often used to provide extensive
mRNA expression data [53-56]. Gene arrays provide
profiles of functional gene clusters using a variety of bio-
informatic approaches [34,35]. Youshimura et al. previ-
ously reported the temporal and spatial expression of
immediate early genes in retinal neurons after retinal I/R
injury [57]. Hollborn et al., also specifically identifiedinflammatory and immune-response-related genes acti-
vated in the early stage of experimental retinal detach-
ment [58]. In addition, Kamphuis et al. evaluated
changes in retinal gene expression following ischemic
preconditioning [59]. In our study, we performed cDNA
microarray analysis at 8 different time points after ret-
inal I/R injury and verified their differential expression
with real-time RT-PCR (Figures 8 and 9). Based on our
gene clustering data, we observed temporal changes of
several genes related with signaling pathways, structure/
cellular stress and inflammation, based on their relation
with ischemic diseases in the retina or other tissues. For
example, Stat3 is protective in various ischemic diseases
including retinal I/R injury [30]. Modulation of glutathi-
one peroxidase (gpx) expression has been reported
under ischemic environments in various tissues [60-63].
bcl6 was originally known as a modulator of STAT-
dependent interleukin-4 (IL-4) response in B cells [64].
bcl6 is induced in circulated leukocytes after ischemic
stroke, but its precise role in this condition is unknown
[65]. Caspase8 is a major molecule in the apoptotic cas-
cade involved in ischemia-induced cell death [66,67]. Al-
though crystallins were originally known as structural
proteins in lens [68-70] crystallins also are molecular
chaperones structurally similar to small heat shock pro-
tein (hsp) with the ability to prevent protein aggregation
[70-73]. Altered expression of the crystallins has been
observed in various ocular diseases such as diabetic ret-
inopathy, uveitis and glaucoma [74-78]. However, no
clear changes in crystallin expression has been shown
previously in retinal I/R injury.
One of the most interesting changes was the up-
regulation of various inflammatory genes including c3,
c4b, ccl12, and gfap (Figures 8, 9, 10). In particular, sev-
eral researchers discovered that complement compo-
nents play important roles in eye development and
ocular pathology such as glaucoma [79]. In addition,
genetic disruption of c3 protected mice against retinal I/
R injury [32]. Both c3 and c4b genes encode C3 and C4b
proteins, essential for the classical complement cascade
[80,81]. Expression of these proteins is temporally regu-
lated and may play differential roles at different times
Figure 8 I/R injury induced changes in retinal gene expression. After normalizing to control eyes, changes of gene expression ratios in I/R-
injured eyes were plotted based on log2 fold change values through 8 time points (0, 6 hr, 1, 3, 7, 14, 21 and 28 days) after I/R injury. Time
dependent changes in gene expression for three signaling pathways are shown. Among various genes, changes of 12 genes were plotted based
on their functional aspects such as signaling pathway related with (A) cell death/protection, (B) function as a molecular chaperone, and
(C) inflammation.
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Table 2 Gene ontology clusters downregulated in the mouse retina at various time points after I/R injury
Time Ontology Enrichment score P value (P < 0.05)
0 day No significant changes
6hr CC extracellular region 1.64 3.10E-02
1 day No significant changes
3 day BP protein-DNA complex assembly 1.63 7.20E-03
MF DNA binding 1.63 2.10E-02
CC protein-DNA complex 1.63 8.30E-03
7 day No significant changes
14 day BP eye development 1.9 4.70E-02
MF structural constituent of eye lens 1.9 1.40E-03
21 day No significant changes
28 day BP G-protein coupled receptor protein signaling pathway 3.16 3.10E-05
CC integral to membrane 3.16 5.00E-02
Microarray data were filtered for selection of downregulated genes lower than -1.5 fold (log2) after normalizing with control eyes. Data were further analyzed
using DAVID and clustered according to ontology with 3 categories (BP, MF and CC) at 8 time points (0 hr, 6 hr, 1, 3, 7, 14, 21 and 28 days) after I/R injury.
Figure 9 Retinal mRNA expression of cryaa, cryba1 and ccl12 was significantly increased at 24 hr after I/R injury. mRNA expression of
cryaa, cryba1, ccl12 and c3 from I/R injured eyes was analyzed at 8 times points (0, 6hr, 1, 3, 7, 14, 21 and 28 days) by real time RT-PCR to confirm
our microarray data. All data were normalized to gapdh expression followed by further normalizing to control eye data. Data represent mean ±
standard error of relative fold increase of each gene compared to 0 hr expression set at 1. Asterisks indicate statistical differences (p < 0.05)
between 0 hr and each time point.
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Figure 10 I/R injury induced progressive gliosis in the retina. Expression of retinal glial fibrillary acidic protein (GFAP) was monitored by
immunohistochemistry at 5 time points (3, 7, 14, 21 and 28 days) after I/R injury. GFAP expression progressively increased through the retinal
layers in I/R eyes compared to control eyes. Green fluorescence (Alexaflour 488) = GFAP. Nuclei were stained with DAPI (blue fluorescence).
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observed in Müller cells during retinal injury
[39,82,83]. Like other glial cells in neuronal system,
Müller cells play a pivotal role to maintain retinal
neuron homeostasis, such as scavenging neurotrans-
mitter/waste products, supplying energy for retinal
neurons, and other protective and maintenance roles
for neurons [84,85]. Under pathological conditions,
Müller cells are activated, undergoing functional andmorphological changes associated with gliosis [39,82].
Hirrlinger et al. demonstrated that transient retinal ische-
mia in mice induced Müller cell gliosis accompanied by al-
tered protein expression and changes in membrane
properties [86]. Our data provide further support for
Müller cell-dependent retinal gliosis, involving changes in
gene and protein expression as well as Müller cell mor-
phological changes that correlate with progression of I/R
injury.
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in the inner retina, significantly increased within 3 days
of retinal I/R injury. It is likely that this increased retinal
thickness was due to retinal edema. Others have shown
that the increased retinal thickness in retinal ischemia is
due to retinal edema, which may be mediated by ET-1 in
endothelial cells [12]. Retinal edema plays a major role
in the pathogenesis of other types of retinal injury, in-
cluding retinal vessel occlusion and diabetic retinopathy.
In addition, progressive retinal degeneration following
edema in our model was also strongly correlated with
significant cell loss in the RGCL, including RGC and
displaced amacrine cells. Immunohistological assessment
using RGC specific antibodies to Brn3a and NeuN
showed RGC loss induced by I/R injury. Interestingly, a
similar cell loss ratio from histology data (~30%) was
also shown in our immunohistochemistry data (~30%) at
28 days after I/R injury. These data suggest that I/R in-
jury caused cell loss of both RGC and displaced ama-
crine cells in the RGCL. In support, Kim et al.,
previously showed that retinal I/R injury induced apop-
totic cell death to both RGCs and displaced amacrine
cells [87].
One of our novel observations is I/R-induced retinal
detachment (Figure 1). Retinal detachment is a major
cause of vision loss in various ocular pathologies, includ-
ing age-related macular degeneration (AMD) [88-90].
We first observed the retinal detachment in all ischemic
eyes by SD-OCT scanning at days 3 and 7 after I/R in-
jury, but this detachment disappeared at 14 days. We
took advantage of SD-OCT scanning to monitor the
real-time morphological status of the retina without sac-
rificing mice. Interestingly, Zeng et al. developed a novel
mouse model of retinal detachment using a similar can-
nulation method [91]. In contrast to our data, retinal de-
tachment completely recovered within 24 hrs in their
model. In support, Uckermann et al. also suggested that
transient retinal ischemia in rabbits can cause exudative
detachment of the retina through days 3 and 8, which
was accompanied by changes in Müller cell K+ conduct-
ance [92]. They suggested fluid-mediated retinal detach-
ment as a novel ischemia-mediated damage to the ONL.
Our findings also support retinal detachment as another
potential pathologic mechanism for temporal retinal
dysfunction and degeneration. Our ERG a-wave data,
which is associated with outer retinal photoreceptor
function, also support this finding (Figure 6). Retinal de-
tachment was associated with ERG a-wave amplitude
deficits from days 21-28 after I/R injury. Interestingly, a-
wave amplitudes recovered at 35 days, correlating with
recovery of retinal detachment. These results suggest
that early retinal detachment causes delayed outer retina
ERG deficits that are reversible after retinal reattach-
ment. Therefore, retinal detachment in the mousemodel of retinal I/R may contribute to overall ischemia-
mediated retinal damage.
Interestingly, all of our data showed strong temporal
correlations. We detected thickening of the whole retina,
especially the inner retina, 3-7 days after I/R injury.
Fourteen days post I/R injury, four significant changes
simultaneously occurred including: (1) decreased inner
retinal layer thickness, (2) significant loss of cells in
RGC layer, (3) significant changes in gene expression
profiles, and (4) increased GFAP immunostaining
(gliosis) throughout entire retina. Functional impairment
(i.e. decreased ERG responses) began 7 days after I/R in-
jury, suggesting decreased retinal function was due to
early retinal edema and/or damaged retinal cells prior to
morphological degeneration. Our findings are the first to
demonstrate temporal morphological changes accom-
panied with functional and molecular changes associated
with progression of retinal I/R injury.
In conclusion, transient I/R induced morphological
changes mainly in the inner retina that were strongly as-
sociated with functional impairment as well as temporal
changes in retinal gene expression. Our data also indi-
cated that retinal detachment was induced by retinal is-
chemia in the early stages of injury. Our characterization
of temporal retinal changes produced by retinal ischemia
will lead to a better understanding of molecular patho-
genesis associated with this injury as well as suggest
novel therapeutic approaches to mitigate this retinal
damage. Future studies will identify cellular and molecu-
lar mechanisms associated with I/R damage to the optic
nerve and visual axis in the brain. This will lead to the
discovery of new neuroprotective strategies and agents
for the treatment of the retina, optic nerve, and visual
axis in the brain associated with retinal I/R injury.
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